Sat, Feb 28, 2015, 2:51 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • ccharles792 ccharles792 Dec 11, 2012 12:38 AM Flag

    James Stocklaser Who said BUY ACAD, Now Says CELG is STRONG BUY. ((link))

    Seeking: James Stocklaser Who said BUY ACAD, Now Says CELG is STRONG BUY. ((link))
    A Reasoned Case For Celsion's ThermoDox
    December 10, 2012 BY:
    James Stocklasar Thomas Jr
    I think it's common knowledge that any therapy that promotes progression free recurrence is a global billion dollar plus market opportunity. As others have pointed out, with ThermoDox targeting multiple medical indications, the long-term market opportunity is a billion dollar multiple. Seeing how Celsion has already extended the ThermoDox footprint into the European and Asia markets along with the rest of the world including the United States, I hesitate to imagine how high on phase III success the company's share price could rise as events unfold. Therefore, priced in the $7's/share and taking every risk into account, I conclude based on my three-prong study that Celsion is a VERY STRONG BUY.

4.51-0.240(-5.05%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.